In a placebo-controlled, randomized trial, researchers tested the efficacy of cytisinicline—a smoking cessation medication—for those who would like to quit smoking.
To reduce the amount of tobacco-related disease and death in the United States, the FDA is proposing additional action on flavored cigarettes and cigars.
In this commentary, Michael J. Bloch, MD, writes about smoking as a risk factor for coronary heart disease and stroke, the need for clinicians to devote time and resources to smoking cessation interventions...
The prevalence of e-cigarette use and prediabetes is increasing within the United States. To better understand the relationship between e-cigarette use and prediabetes, the researchers examined a large,...
